Anti-diabetic action of Punica granatum flower extract: Activation of PPAR-γ and identification of an active component

Toxicology and Applied Pharmacology

Volumn 207, Issue 2, 2005, Pages 160-169

  Huang, Tom H W ^a   Peng, Gang ^a   Kota, Bhavani P ^a   Li, George Q ^a   Yamahara, Johji ^b   Roufogalis, Basil D ^a   Li, Yuhao ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Pharmafood Institute   (Japan)

Author keywords

Diabetes; Gallic acid; Hyperglycemia; PPAR ; Punica granatum; Zucker diabetic fatty rats

Indexed keywords

ANTIDIABETIC AGENT; GALLIC ACID; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR; LIPOPROTEIN LIPASE; PUNICA GRANATUM EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FLOWER; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; RAT; RAT STRAIN;

ANIMALS; FLOWERS; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 4; HYPOGLYCEMIC AGENTS; MACROPHAGES; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; PLANT EXTRACTS; PPAR GAMMA; PUNICACEAE; RATS; RATS, ZUCKER; RNA, MESSENGER;

ANIMALIA; PUNICA GRANATUM;

EID: 23044467570     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2004.12.009     Document Type: Article

References (43)

1. A. Abe, Y. Kiriyama, M. Hirano, T. Miura, H. Kamiya, H. Harashima, and Y. Tokumitsu Troglitazone suppresses cell growth of KU812 cells independently of PPARgamma Eur. J. Pharmacol. 436 2002 7 13
2. E.D. Abel Glucose transport in the heart Front. Biosci. 9 2004 201 215
3. M. Aviram, L. Dornfeld, M. Kaplan, R. Coleman, D. Gaitini, S. Nitecki, A. Hofman, M. Rosenblat, N. Volkova, D. Presser, J. Attias, T. Hayek, and B. Fuhrman Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans Drugs Exp. Clin. Res. 28 2002 49 62
4. D.D. Belke, T.S. Larsen, E.M. Gibbs, and D.L. Severson Glucose metabolism in perfused mouse hearts overexpressing human GLUT-4 glucose transporter Am. J. Physiol.: Endocrinol. Metab. 280 2001 E420 E427
5. D. Bishop-Bailey, and J. Wray Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation Prostaglandins Other. Lipid. Mediat. 71 2003 1 22
6. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of dye-binding Anal. Biochem. 72 1976 248 254
7. K.K. Brown, B.R. Henke, S.G. Blanchard, J.E. Cobb, R. Mook, I. Kaldor, S.A. Kliewer, J.M. Lehmann, J.M. Lenhard, W.W. Harrington, P.J. Novak, W. Faison, J.G. Binz, M.A. Hashim, W.O. Oliver, H.R. Brown, D.J. Parks, K.D. Plunket, W.Q. Tong, J.A. Menius, K. Adkison, S.A. Noble, and T.M. Willson A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat Diabetes 48 1999 1415 1424
8. A.N. Carley, L.M. Semeniuk, Y. Shimoni, E. Aasum, T.S. Larsen, J.P. Berger, and D.L. Severson Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function Am. J. Physiol.: Endocrinol. Metab. 286 2004 E449 E455
9. A. Chawla, W.A. Boisvert, C.H. Lee, B.A. Laffitte, Y. Barak, S.B. Joseph, D. Liao, L. Nagy, P.A. Edwards, L.K. Curtiss, R.M. Evans, and P. Tontonoz A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis Mol. Cell 7 2001 161 171
10. P. Dandona Insulin resistance and endothelial dysfunction in atherosclerosis: implications and interventions Diabetes Technol. Ther. 4 2002 809 815
11. A.K. Das, S.C. Mandal, S.K. Banerjee, S. Sinha, B.P. Saha, and M. Pal Studies on the hypoglycaemic activity of Punica granatum seed in streptozotocin induced diabetic rats Phytother. Res. 15 2001 628 629
12. G.F. Davies, P.J. Mcfiem, R.L. Khandelwal, and W.J. Roesler Unique ability of troglitazone to up-regulate peroxisome proliferator-activated receptor-γ expression in hepatocytes J. Pharmacol. Exp. Ther. 300 2002 72 77
13. M. Desrois, R.J. Sidell, D. Gauguier, C.L. Davey, G.K. Radda, and K. Clarke Gender differences in hypertrophy, insulin resistance and ischemic injury in the aging type 2 diabetic rat heart J. Mol. Cell. Cardiol. 37 2004 547 555
14. G.A. Francis, J.S. Annicotte, and J. Auwerx PPAR agonists in the treatment of atherosclerosis Curr. Opin. Pharmacol. 3 2003 186 191
15. C. Furnsinn, and W. Waldhausl Thiazolidinediones: metabolic actions in vitro Diabetologia 45 2002 1211 1223
16. A.J. Gilde, and M. Van Bilsen Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle Acta Physiol. Scand. 178 2003 425 434
17. J.K. Grover, S. Yadav, and V. Vats Medicinal plants of India with anti-diabetic potential J. Ethnophrmacol. 81 2002 81 100
18. J.L. Hall, W.L. Sexton, and W.C. Stanley Exercise training attenuates the reduction in myocardial GLUT-4 in diabetic rats J. Appl. Physiol. 78 1995 76 81
19. K.L. Houseknecht, B.M. Cole, and P.J. Steele Peroxisome proliferator-activated receptor gamma (PPAR) and its ligands: a review Domest. Anim. Endocrinol. 22 2002 1 23
20. M.A. Jafri, M. Aslam, K. Javed, and S. Singh Effect of Punica granatum Linn. (Flowers) on blood glucose level in normal and alloxan-induced diabetic rats J. Ethnopharmacol. 70 2000 309 314
21. Jurjani, M.I., 1878. Zakheera-Khwarzam-Shahi. Munshi Nawal Kishore, Lucknow, 540 (Urdu translation).
22. B.L. Kasiske, M.P. O'Donnell, and W.F. Keane The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury Hypertension 19 1992 110 115
23. B.H. Kroes, A.J. van den Berg, H.C. Quarles van Ufford, H. van Dijk, and R.P. Labadie Anti-inflammatory activity of gallic acid Planta Med. 58 1992 499 504
24. L.M. Leesnitzer, D.J. Parks, R.K. Bledsoe, J.E. Cobb, J.L. Collins, T.G. Consler, R.G. Davis, E.A. Hull-Ryde, J.M. Lenhard, L. Patel, K.D. Plunket, J.L. Shenk, J.B. Stimmel, C. Therapontos, T.M. Willson, and S.G. Blanchard Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662 Biochemistry 41 2002 6640 6650
25. L. Li, M.C. Beauchamp, and G. Renier Peroxisome proliferator-activated receptor alpha and gamma agonists upregulate human macrophage lipoprotein lipase expression Atherosclerosis 165 2002 101 110
26. G.D. Lopaschuk Metabolic abnormalities in the diabetic heart Heart Fail. Rev. 7 2002 149 159
27. Majoosi, A.I.A., 1889. Kamilussanah. Munshi Nawal Kishore, Lucknow 145 (Urdu translation).
28. A.C. Nicholson, J. Han, M. Febbraio, R.L. Silversterin, and D.P. Hajjar Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis Ann. N. Y. Acad. Sci. 947 2001 224 228
29. D.G. Nogueira, and N.A. Pereira Effect of an alcoholic extract from the epicarp of roma (Punica granatum L.) on insulin hypoglycaemia Rev. Bras. Farm. 67 1986 59 61
30. C. Otto, M. Lehrke, and B. Goke Novel insulin sensitizers: pharmacogenomic aspects Pharmacogenomics 3 2002 99 116
31. F. Sanae, Y. Miyaichi, and H. Hayashi Endothelium-dependent contraction of rat thoracic aorta induced by gallic acid Phytother. Res. 17 2003 187 189
32. S.Y. Schubert, E.P. Lansky, and I. Neeman Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids J. Ethnopharmacol. 66 1999 11 17
33. R.J. Sidell, M.A. Cole, N.J. Draper, M. Desrois, R.E. Buckingham, and K. Clarke Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart Diabetes 51 2002 1110 1117
34. J. Song, M.A. Knepper, X. Hu, J.G. Verbalis, and C.A. Ecelbarger Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats J. Pharmacol. Exp. Ther. 308 2004 426 433
35. W.C. Stanley, G.D. Lopaschuk, and K.M. Kivilo Alterations in myocardial energy metabolism in streptozotocin diabetes J.H. McNeill Experimental Models of Diabetes 1999 CRC Press 19 38
36. M. Stumvoll, and H. Haring The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism Diabetes 51 2002 2341 2347
37. C.K. Sung, H. She, S. Xiong, and H. Tsukamoto Tumor necrosis factor-inhibits peroxisome proliferator-activated receptor activity at a posttranslational level in hepatic stellate cells Am. J. Physiol.: Gastrointest. Liver Physiol. 286 2004 G722 G729
38. T. Takagi, Y. Naito, N. Tomatsuri, O. Handa, H. Ichikawa, N. Yoshida, and T. Yoshikawa Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade Redox Rep. 7 2002 283 289
39. T.M. Willson, P.J. Brown, D.D. Sternbach, and B.R. Henke The PPARs: from orphan receptors to drug discovery J. Med. Chem. 43 2000 527 550
40. Z. Wu, Y. Xie, R.F. Morrison, N.L. Bucher, and S.R. Farmer PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes J. Clin. Invest. 101 1998 22 32
41. L.H. Young, Y. Renfu, R. Russell, X. Hu, M. Caplan, J. Ren, G.I. Shulman, and A.J. Sinusas Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo Circulation 95 1997 415 422
42. R. Zafar, and J. Singh Antidiabetic activity of Punica granatum Linn Sci. Cult. 56 1990 3
43. A. Zisman, O.D. Peroni, E.D. Abel, M.D. Michael, F. Mauvais-Jarvis, B.B. Lowell, J.F. Wojtaszewski, M.F. Hirshman, A. Virkamaki, L.J. Goodyear, C.R. Kahn, and B.B. Kahn Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance Nat. Med. 6 2000 924 928